Mealey's (August 14, 2019, 1:35 PM EDT) -- ALEXANDRIA, Va. — In an Aug. 9 patent owner response, a pharmaceutical company criticized a recently filed petition for inter partes review (IPR) as “riddled” with hindsight bias in asserting obviousness (Amneal Pharmaceuticals LLC v. Almirall LLC, No. IPR2019-00207, PTAB)....